Sumatriptan News
Actavis launches three new generic products in Europe
Actavis is one of the first to launch three new generic products into a number of key European markets including Germany, the UK, Hungary and Poland. The drugs include Sumatriptan, used to treat migraine headaches, the atypical...
Migraine drug eases severe face pain
One of the severest pains that can be experienced is trigeminal neuralgia, affecting nerves in the face, and few medications relieve the condition. Now, for people with treatment-resistant trigeminal neuralgia, a migraine...
UK approves OTC sales of Imigran
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) said on Friday that GlaxoSmithKline's Imigran (sumatriptan) could be safely sold through pharmacies without a prescription for the acute relief of migraine...
Subcutaneous Sumatriptan Treats Refractory Trigeminal Neuralgia CME
For patients with idiopathic, treatment-refractory trigeminal neuralgia, subcutaneous sumatriptan produces rapid and significant pain relief that lasts for about 8 hours without serious adverse reactions, according to results of...
Mylan Laboratories Inc. (MYL) Announces Tentative Approval For Sumatriptan Succinate Tablets
Mylan Laboratories Inc. today announced that the U.S. Food and Drug Administration has granted tentative approval for Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application for Sumatriptan Succinate Tablets 25 mg (base),...